A new portable ultrasound device designed for rapid triaging and monitoring of patients with brain disorders has been cleared by the FDA. The Lucid System uses Trans Cranial Doppler to non-invasively assess the brain’s blood vessels from outside the body. The battery powered medical tablet device, which can be performed in a physician’s office and in a range of settings, can help in the diagnosis brain disorders, potentially without the need for additional, more invasive tests, according to manufacturer Neural Analytics. The Lucid System is the first product the company will sell commercially.
For more information, visit www.neuralanalytics.com.Next Story